Nocturia is the lower urinary tract symptom with greatest impact on quality of life of men from a community setting

International Neurourology Journal

Volumn 18, Issue 2, 2014, Pages 86-90

  de Paula Miranda, Eduardo ^a   Gomes, Cristiano Mendes ^a   Torricelli, Fábio César Miranda ^a   de Bessa Júnior, José ^b   de Castro, José Everton ^b   da Silva Ferreira, Bruno Roberto ^b   Scafuri, Ariel Gustavo ^b   Bruschini, Homero ^a   Srougi, Miguel ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Epidemiology; Lower urinary tract symptoms; Nocturia; Prostatic hyperplasia; Quality of life

Indexed keywords

ADULT; AGED; ARTICLE; CROSS-SECTIONAL STUDY; HUMAN; IMPAIRED BLADDER EMPTYING; INTERNATIONAL PROSTATE SYMPTOM SCORE; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; NOCTURIA; QUALITY OF LIFE; URINARY FREQUENCY; URINARY URGENCY;

EID: 84903576724     PISSN: 20934777     EISSN: 20936931     Source Type: Journal    
DOI: 10.5213/inj.2014.18.2.86     Document Type: Article

References (21)

1. Bosch JL, Weiss JP. The prevalence and causes of nocturia. J Urol 2010; 184:440-6.
2. Angalakuditi M, Seifert RF, Hayes RP, O'Leary MP, Viktrup L. Measurement properties of the benign prostatic hyperplasia impact index in tadalafil studies. Health Qual Life Outcomes 2010; 8:131.
3. Kim SO, Choi HS, Kim YJ, Kim HS, Hwang IS, Hwang EC, et al. Impact of nocturia on health-related quality of life and medical outcomes study sleep score in men. Int Neurourol J 2011; 15:82-6.
4. Badía X, Garcia-Losa M, Dal-Re R. Ten-language translation and harmonization of the International Prostate Symptom Score: developing a methodology for multinational clinical trials. Eur Urol 1997; 31:129-40.
5. Yoshimura K, Arai Y, Ichioka K, Terada N, Matsuta Y, Okubo K. Symptom-specific quality of life in patients with benign prostatic hyperplasia. Int J Urol 2002; 9:485-90.
6. Ushijima S, Ukimura O, Okihara K, Mizutani Y, Kawauchi A, Miki T. Visual analog scale questionnaire to assess quality of life specific to each symptom of the International Prostate Symptom Score. J Urol 2006; 176:665-71.
7. Batista-Miranda JE, Molinuevo B, Pardo Y. Impact of lower urinary tract symptoms on quality of life using Functional Assessment Cancer Therapy scale. Urology 2007; 69:285-8.
8. Van Dijk MM, Wijkstra H, Debruyne FM, De La Rosette JJ, Michel MC. The role of nocturia in the quality of life of men with lower urinary tract symptoms. BJU Int 2010; 105:1141-6.
9. Sountoulides P, van Dijk MM, Wijkstra H, de la Rosette JJ, Michel MC. Role of voiding and storage symptoms for the quality of life before and after treatment in men with voiding dysfunction. World J Urol 2010; 28:3-8.
10. McVary KT, Roehrborn CG, Avins AL, Barry MJ, Bruskewitz RC, Donnell RF, et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol 2011; 185:1793-803.
11. Blanker MH, Bohnen AM, Groeneveld FP, Bernsen RM, Prins A, Ruud Bosch JL. Normal voiding patterns and determinants of increased diurnal and nocturnal voiding frequency in elderly men. J Urol 2000; 164:1201-5.
12. Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 2006; 50:1306-14.
13. Boongird S, Shah N, Nolin TD, Unruh ML. Nocturia and aging: diagnosis and treatment. Adv Chronic Kidney Dis 2010;17:e27-40.
14. Coyne KS, Sexton CC, Thompson CL, Milsom I, Irwin D, Kopp ZS, et al. The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study. BJU Int 2009; 104:352-60.
15. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function:report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002; 21:167-78.
16. Masumori N, Tanaka Y, Takahashi A, Itoh N, Ogura H, Furuya S, et al. Lower urinary tract symptoms of men seeking medical care--comparison of symptoms found in the clinical setting and in a community study. Urology 2003; 62:266-72.
17. Wang Y, Xu K, Hu H, Zhang X, Wang X, Na Y, et al. Prevalence, risk factors, and impact on health related quality of life of overactive bladder in China. Neurourol Urodyn 2011; 30:1448-55.
18. Coyne KS, Sexton CC, Kopp ZS, Ebel-Bitoun C, Milsom I, Chapple C. The impact of overactive bladder on mental health, work productivity and health-related quality of life in the UK and Sweden: results from EpiLUTS. BJU Int 2011; 108:1459-71.
19. Sagnier PP, MacFarlane G, Teillac P, Botto H, Richard F, Boyle P. Impact of symptoms of prostatism on level of bother and quality of life of men in the French community. J Urol 1995;153(3 Pt 1):669-73.
20. Andersson SO, Rashidkhani B, Karlberg L, Wolk A, Johansson JE. Prevalence of lower urinary tract symptoms in men aged 45-79 years: a population-based study of 40 000 Swedish men. BJU Int 2004; 94:327-31.
21. Asplund R. Mortality in the elderly in relation to nocturnal micturition. BJU Int 1999; 84:297-301.